GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » Median PS Value

Biohit Oyj (OHEL:BIOBV) Median PS Value : €4.46 (As of May. 13, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Biohit Oyj's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.864. Biohit Oyj's 10-Year median PS Ratio is 5.162. Therefore, the Median PS Value for today is €4.46.

As of today (2024-05-13), Biohit Oyj's share price is €2.00. Biohit Oyj's Median PS Value is €4.46. Therefore, Biohit Oyj's Price to Median PS Value for today is 0.45.

The historical rank and industry rank for Biohit Oyj's Median PS Value or its related term are showing as below:

OHEL:BIOBV' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.25   Med: 0.44   Max: 15.23
Current: 0.45

During the past 13 years, the highest Price to Median PS Value of Biohit Oyj was 15.23. The lowest was 0.25. And the median was 0.44.

OHEL:BIOBV's Price-to-Median-PS-Value is ranked better than
68.73% of 259 companies
in the Biotechnology industry
Industry Median: 0.69 vs OHEL:BIOBV: 0.45

Biohit Oyj Median PS Value Historical Data

The historical data trend for Biohit Oyj's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj Median PS Value Chart

Biohit Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.78 5.49 7.22 5.84 4.46

Biohit Oyj Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.22 - 5.84 - 4.46

Competitive Comparison of Biohit Oyj's Median PS Value

For the Biotechnology subindustry, Biohit Oyj's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biohit Oyj's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biohit Oyj's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's Price-to-Median-PS-Value falls into.



Biohit Oyj Median PS Value Calculation

Biohit Oyj's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.864*5.162
=4.46

10-Year Median PS Ratio is 5.162.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biohit Oyj's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.864.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohit Oyj  (OHEL:BIOBV) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Biohit Oyj's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=2.00/4.46
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohit Oyj Median PS Value Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Biohit Oyj (OHEL:BIOBV) Business Description

Traded in Other Exchanges
N/A
Address
Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines